20 May 2003 : Original article
Comparative efficacy of interferon therapy (IFT)in patients with chronic hepatitis C (CHC)depending on histological grade and stage
N. Matievskaya, N. Prokopchik, V. TsyrkunovMed Sci Monit 2003; 9(2): 11-12 :: ID: 15257
Abstract
Background:To compare the efficacy of IFT in patients depending on the histological activity degree and disease stage.Material/Methods: The results of IFT have been analysed in 50 patients with CHC.There are 40 males and 10 females in the studied group.Mean age of patients was 36.6 ±16.6.All the patients underwent liver biopsy before IFT and in 6 months after its accomplishment.The histological examination has been made according to Knodell scoring system.31 patients had CHC of mild activity (a necroinflammatory score was in range 1 –8),19 patients –of moderate activity (a necroinflammatory score was in range 9 –12).Fibrosis score of 0 was in 10 patients, fibrosis score of 1 –in 24 patients,fibrosis score of 3 –in 15 patients.All the patients were receiving monotherapy with a -2 b Interferon preparations within 6 months.The groups were compared according to biochemical response rate (BR),namely,reduction of ALT activity on the background of IFT,virological response (VR)–disappearance of RNA HCV after IFT course,morphological response (MR)–reduction of inflammation and fibrosis degree in the control biopsy.Results:The rate of BR did not differ significantly in patients with hepatitis of mild activity in comparison with ones who had hepatitis of moderate activity (25/31 v.6/19,respectively, p>0.05).VR was in 10/31 patients with hepatitis of mild activity v.4/19 patients with hepatitis of moderate activity (p>0.05),MR was in 30/31 patients with hepatitis of mild activity and in 6/19 patients with hepatitis of moderate activity (p>0.05).BR was found out evidently more frequently in patients with fibrosis 0 in comparison with the patients who had fibrosis 3 (9/10 patients v.6/15,respectively p0.3).VR was significantly more frequent in patients with fibrosis 0 as compared with the patients having fibrosis 1 and fibrosis 3(7/10 v.4/24,p0.05).Conclusions:1.Patients with chronic hepatitis C and progressive fibrosis stage had significantly low rate of BR and VR on IFT in comparison with ones who did not have fibrosis in liver biopsy,it should be taken into consideration while admi- nistering IFT.2.Histological activity degree did not influence on the efficacy of IFT in the studied group.
Editorial
01 April 2025 : Editorial
Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to HumansDOI: 10.12659/MSM.949109
Med Sci Monit 2025; 31:e949109
In Press
Clinical Research
Use of The Mirror-Image Technique for Patient-Specific Reconstruction of Cuboid FracturesMed Sci Monit In Press; DOI: 10.12659/MSM.947437
Laboratory Research
Retention of 3-D-Printed, Milled, and Conventionally Fabricated Occlusal SplintsMed Sci Monit In Press; DOI: 10.12659/MSM.947342
Review article
A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitor...Med Sci Monit In Press; DOI: 10.12659/MSM.949300
Clinical Research
Buccal Acupuncture Reduces the Dose of Sufentanil Needed in Laparoscopic Gynecological SurgeryMed Sci Monit In Press; DOI: 10.12659/MSM.947088
Most Viewed Current Articles
17 Jan 2024 : Review article 7,932,846
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,905
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 29,808
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 23,790
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912